Pei Fang Tan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pei Fang Tan has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Ai Ling Teh
Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research, Brenner Centre for Molecular Medicine, Singapore 117609, Singapore
1 shared publication- Aleidy Silva
Department of Mechanical and Aerospace Engineering, University of California, Los Angeles, California, United States of America
1 shared publication - Allan Lawrie
National Heart and Lung Institute, Imperial College London, London, UK
1 shared publication - Chih-Ming Ho
University of California, Los Angeles
1 shared publication - Christopher J. Rhodes
Imperial College London
1 shared publication - Dean Ho
The Institute for Digital Medicine (WisDM), Yong Loo Lin School of Medicine, National University of Singapore
1 shared publication
Latest Publications
- Open Access
- 2 January 2024
- Published by Oxford University Press (OUP) in GigaScience
- Vol. 13
Omada: robust clustering of transcriptomes through multiple testing
Background: Cohort studies increasingly collect biosamples for molecular profiling and are observing molecular heterogeneity. High-throughput RNA sequencing is providing large datasets capable of reflecting disease mechanisms. Clustering approaches have produced a number of tools to help dissect complex heterogeneous datasets, but selecting the appropriate method and parameters to perform exploratory clustering analysis of transcriptomic data requires deep understanding of machine learning and extensive computational experimentation. Tools that assist with such decisions without prior field knowledge are nonexistent. To address this, we have developed Omada, a suite of tools aiming to automate these processes and make robust unsupervised clustering of transcriptomic data more accessible through automated machine learning–based functions. Findings: The efficiency of each tool was tested with 7 datasets characterized by different expression signal strengths to capture a wide spectrum of RNA expression datasets. Our toolkit’s decisions reflected the real number of stable partitions in datasets where the subgroups are discernible. Within datasets with less clear biological distinctions, our tools either formed stable subgroups with different expression profiles and robust clinical associations or revealed signs of problematic data such as biased measurements. Conclusions: In conclusion, Omada successfully automates the robust unsupervised clustering of transcriptomic data, making advanced analysis accessible and reliable even for those without extensive machine learning expertise. Implementation of Omada is available at http://bioconductor.org/packages/omada/.
- 2 January 2024
- Published by Oxford University Press (OUP) in GigaScience
- Vol. 13
Open AccessOmada: robust clustering of transcriptomes through multiple testing
Background: Cohort studies increasingly collect biosamples for molecular profiling and are observing molecular heterogeneity. High-throughput RNA sequencing is providing large datasets capable of reflecting disease mechanisms. Clustering approaches have produced a number of tools to help dissect complex heterogeneous datasets, but selecting the appropriate method and parameters to perform exploratory clustering analysis of transcriptomic data requires deep understanding of machine learning and extensive computational experimentation. Tools that assist with such decisions without prior field knowledge are nonexistent. To address this, we have developed Omada, a suite of tools aiming to automate these processes and make robust unsupervised clustering of transcriptomic data more accessible through automated machine learning–based functions. Findings: The efficiency of each tool was tested with 7 datasets characterized by different expression signal strengths to capture a wide spectrum of RNA expression datasets. Our toolkit’s decisions reflected the real number of stable partitions in datasets where the subgroups are discernible. Within datasets with less clear biological distinctions, our tools either formed stable subgroups with different expression profiles and robust clinical associations or revealed signs of problematic data such as biased measurements. Conclusions: In conclusion, Omada successfully automates the robust unsupervised clustering of transcriptomic data, making advanced analysis accessible and reliable even for those without extensive machine learning expertise. Implementation of Omada is available at http://bioconductor.org/packages/omada/.
- 8 August 2018
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 10 (453)
Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP)
A drug discovery and optimization platform uncovered effective therapeutic combinations for bortezomib-resistant multiple myeloma.
- 8 August 2018
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 10 (453)
Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP)
A drug discovery and optimization platform uncovered effective therapeutic combinations for bortezomib-resistant multiple myeloma.